19 June 2013
Keywords: BB Biotech, Vontobel Group, Restructuring, Privatization, Investment fund
Article | 16 July 2012
Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made a proposal to restructure ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 July 2012
18 June 2013
© 2013 thepharmaletter.com